市場調查報告書
商品編碼
1063450

末稍血管栓塞保護裝置(心血管) - 全球市場的分析與預測模式

Peripheral Embolic Protection Devices (Cardiovascular) - Global Market Analysis and Forecast Model

出版日期: | 出版商: GlobalData | 英文 | 訂單完成後即時交付

價格

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

  • 全貌
  • 簡介
  • 目錄
簡介

本報告提供末稍血管栓塞保護裝置(心血管)市場相關調查,提供2020年以後COVID-19對該市場帶來的影響詳細,產業趨勢,2015年到2030年的市場展望,SWOT分析,競爭情形,各地區,各國分析等全面性資訊。

報告概要

末稍血管栓塞保護裝置市場現狀及競爭格局

  • 主要的產業趨勢的洞察檢討
  • 末稍血管栓塞保護裝置市場年度總收益與市場展望:各市場區隔(2015年∼2030年)
  • 整體治療數,單位,平均銷售價格,有關市場價值的詳細的資料:各市場區隔

世界,地區,國家層級的市場洞察

  • 末稍血管栓塞保護裝置市場SWOT分析
  • 末稍血管栓塞保護裝置市場相關競爭動態的洞察和趨勢
  • 醫療制度概要:各國
  • 償付政策:各國
  • 醫療技術相關法規情形:各國

對象企業:Medtronic plc,Abbott Laboratories,Boston Scientific Corp,Cardinal Health Inc,Allium Medical Solutions Ltd

觀察對象國家:美國,英國,德國,法國,義大利,西班牙,巴西,中國,印度,俄羅斯,日本,澳洲,加拿大,墨西哥,韓國,丹麥,愛爾蘭,荷蘭,紐西蘭,南非,瑞典,瑞士,奧地利,比利時,芬蘭,以色列,挪威,波蘭葡萄牙,台灣,捷克,希臘,匈牙利,土耳其,埃及,沙烏地阿拉伯,阿拉伯聯合大公國,阿根廷,智利

目錄
Product Code: GDME671MM

Peripheral Embolic Protection Devices (Cardiovascular) - Global Market Analysis and Forecast Model (COVID-19 Market Impact) is built to visualize quantitative market trends within Cardiovascular Devices therapeutic area.

The model discusses in detail the impact of COVID-19 on Peripheral Embolic Protection Devices market for the year 2020 and beyond. A narrowing of arteries due to the build-up of plaque occurs in conditions such as peripheral vascular disease, carotid artery stenosis and renal artery stenosis. Angioplasty is a minimally invasive interventional procedure that is used to unblock an artery with excessive plaque build-up in order to restore normal blood flow. Embolic debris may become dislodged during angioplasty procedures, which if left alone can cause a pulmonary embolism. To protect against distal embolic events, EPD are designed to capture and remove debris that may get dislodged during interventional procedures. Present technologies for Embolic Protection Devices (EPD) employ three important strategies: distal occlusion, proximal occlusion and distal filtration.

Each of the covered 39 country's color-coded and fully-sourced market models are equipped with epidemiology based indications with procedure volumes. To increase the data transparency, the interactive excel deliverable covers installed base, new sales volumes, product usage, average selling prices, market size and company share/rank analysis (wherever available). Moreover, analyst comments with qualitative insight offer context for quantitative data.

Key Inclusions of the market model are -

Currently marketed Peripheral Embolic Protection Devices market and evolving competitive landscape -

  • Insightful review of the key industry trends.
  • Annualized total Peripheral Embolic Protection Devices market revenue by segment and market outlooks from 2015-2030.
  • Granular data on total procedures, units, average selling prices and market values by segment.

Global, Regional and Country level market specific insights -

  • Qualitative market specific information is available with global trends further broken down into regional trends. In addition GlobalData analysts provide unique country specific insights on the market.
  • SWOT analysis for Peripheral Embolic Protection Devices market.
  • Competitive dynamics insights and trends provided Peripheral Embolic Protection Devices market.

Drive the understanding of the market by getting the veritable big picture including an overview of the healthcare system. In addition the Market Access segment allows you to delve deeper into market dynamics with information on reimbursement policies and the regulatory landscape.

  • Country specific overview of the healthcare system.
  • Country specific reimbursement policies.
  • Country specific medtech regulatory landscape.

Robust methodologies and sources enable the model to provide extensive and accurate overview of the market. Demand and supply-side primary sources are integrated within the syndicated models, including Key Opinion Leaders. In addition, real world data sources are leveraged to determine market trends; these include government procedure databases, hospital purchasing databases, and proprietary online databases.

Companies covered - Medtronic plc, Abbott Laboratories, Boston Scientific Corp, Cardinal Health Inc, Allium Medical Solutions Ltd

Countries covered - United States, United Kingdom, Germany, France, Italy, Spain, Brazil, China, India, Russia, Japan, Australia, Canada, Mexico, South Korea, Denmark, Ireland, Netherlands, New Zealand, South Africa, Sweden, Switzerland, Austria, Belgium, Finland, Israel, Norway, Poland, Portugal, Taiwan, Czech Republic, Greece, Hungary, Turkey, Egypt, Saudi Arabia, United Arab Emirates, Argentina and Chile.

Scope

This Market Model gives important, expert insight you won't find in any other source. The model illustrates qualitative and quantitative trends within the specified market. This model is required reading for -

  • CMO executives who must have deep understanding of the Peripheral Embolic Protection Devices marketplace to make strategic planning and investment decisions.
  • Sourcing and procurement executives who must understand crucial components of the supply base in order to make decisions about supplier selection and management.
  • Private equity investors that need a deeper understanding of the market to identify and value potential investment targets.

Reasons to Buy

The model will enable you to -

  • Understand the impact of COVID-19 on Peripheral Embolic Protection Devices market.
  • Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies, and by identifying the companies with the most robust pipeline.
  • Develop business strategies by understanding the trends shaping and driving Peripheral Embolic Protection Devices market.
  • Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the Peripheral Embolic Protection Devices market in the future.
  • Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the company share of market leaders.
  • Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.
  • Track device sales in the global and country-specific Peripheral Embolic Protection Devices market from 2015-2030.
  • Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships.